Metformin Study Insights
The discussion highlights the concept of informative censoring in a study comparing metformin users to non-diabetic individuals, raising concerns about the validity of excluding patients who deviated from treatment. A significant finding revealed that the crude death rate for those on metformin was surprisingly lower than that of the control group, sparking intrigue about the potential benefits of the drug in managing type 2 diabetes.In this clip
From this podcast
Huberman Lab
Journal Club with Dr. Peter Attia | Metformin for Longevity & The Power of Belief Effects
Related Questions